{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:42Z","timestamp":1707525042525},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"DOI":"10.7759\/cureus.39143","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T17:36:20Z","timestamp":1684344980000},"source":"Crossref","is-referenced-by-count":0,"title":["Paradoxical Left Ventricular Hypertrophy by Echocardiogram and Low Voltage ECG: A Key Clue in the Diagnostic Workup of Two Distinct Presentations of Cardiac AL Amyloidosis"],"prefix":"10.7759","author":[{"given":"Oluwaremilekun","family":"Tolu-Akinnawo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikelola","family":"Oyeleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Thayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock TP","year":"2018","unstructured":"Quock TP, Yan T, Chang E, Guthrie S, Broder MS. Epidemiology of AL amyloidosis: a real-world study using US claims data. Blood Adv. 2018, 2:1046-1053. 10.1182\/bloodadvances.2018016402","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly JP","year":"2017","unstructured":"Donnelly JP, Hanna M. Cardiac amyloidosis: an update on diagnosis and treatment. Cleve Clin J Med. 2017, 84:12-26. 10.3949\/ccjm.84.s3.02","journal-title":"Cleve Clin J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens W","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al.. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022, 387:1185-1195. 10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon SD","year":"2022","unstructured":"Solomon SD, McMurray JJ, Claggett B, et al.. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022, 387:1089-1098. 10.1056\/NEJMoa2206286","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac\u00a0amyloidosis","volume":"6","author":"Giancaterino S","year":"2020","unstructured":"Giancaterino S, Urey MA, Darden D, Hsu JC. Management of arrhythmias in cardiac\u00a0amyloidosis. JACC Clin Electrophysiol. 2020, 6:351-361. 10.1016\/j.jacep.2020.01.004","journal-title":"JACC Clin Electrophysiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-11-1-53","article-title":"Case report: isolated cardiac amyloidosis: an enigma unravelled","volume":"11","author":"Khalid U","year":"2015","unstructured":"Khalid U, Awar O, Verstovsek G, et al.. Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J. 2015, 11:53-58. 10.14797\/mdcj-11-1-53","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018, 18:30-35. 10.7861\/clinmedicine.18-2-s30","journal-title":"Clin Med (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1975.tb00968.x","article-title":"Amyloid in the aged heart: frequency and clinical significance","volume":"23","author":"Wright JR","year":"1975","unstructured":"Wright JR, Calkins E. Amyloid in the aged heart: frequency and clinical significance. J Am Geriatr Soc. 1975, 23:97-103. 10.1111\/j.1532-5415.1975.tb00968.x","journal-title":"J Am Geriatr Soc"},{"key":"ref9","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle RA","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM, Kurland LT. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992, 79:1817-1822.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2014.08.013","article-title":"Light chain amyloidosis: experience in a tertiary hospital: 2005-2013","volume":"215","author":"Krsnik I","year":"2015","unstructured":"Krsnik I, Cabero M, Morillo D, Segovia J, Garc\u00eda-Pav\u00eda P, G\u00f3mez-Bueno M, Salas C. Light chain amyloidosis: experience in a tertiary hospital: 2005-2013. Rev Clin Esp (Barc). 2015, 215:1-8. 10.1016\/j.rce.2014.08.013","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk RH","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005, 112:2047-2060. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1805","article-title":"Amyloidosis and the heart: a comprehensive review","volume":"166","author":"Shah KB","year":"2006","unstructured":"Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006, 166:1805-1813. 10.1001\/archinte.166.17.1805","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i6.742","article-title":"Cardiac amyloidosis: a case report and review of literature","volume":"7","author":"Taiwo AA","year":"2019","unstructured":"Taiwo AA, Alapati L, Movahed A. Cardiac amyloidosis: a case report and review of literature. World J Clin Cases. 2019, 7:742-752. 10.12998\/wjcc.v7.i6.742","journal-title":"World J Clin Cases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis","volume":"13","author":"Klein AL","year":"1989","unstructured":"Klein AL, Hatle LK, Burstow DJ, et al.. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989, 13:1017-1026. 10.1016\/0735-1097(89)90254-4","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153623.02240.20","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Kwong RY","year":"2005","unstructured":"Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005, 111:122-124. 10.1161\/01.CIR.0000153623.02240.20","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow A","year":"1981","unstructured":"Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation. 1981, 63:1285-1288. 10.1161\/01.cir.63.6.1285","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi S","year":"2015","unstructured":"Longhi S, Quarta CC, Milandri A, et al.. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid. 2015, 22:147-155. 10.3109\/13506129.2015.1028616","journal-title":"Amyloid"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner M","year":"2004","unstructured":"Skinner M, Sanchorawala V, Seldin DC, et al.. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004, 140:85-93. 10.7326\/0003-4819-140-2-200401200-00008","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157118-paradoxical-left-ventricular-hypertrophy-by-echocardiogram-and-low-voltage-ecg-a-key-clue-in-the-diagnostic-workup-of-two-distinct-presentations-of-cardiac-al-amyloidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:48Z","timestamp":1707508908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157118-paradoxical-left-ventricular-hypertrophy-by-echocardiogram-and-low-voltage-ecg-a-key-clue-in-the-diagnostic-workup-of-two-distinct-presentations-of-cardiac-al-amyloidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.39143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}